JP2011520098A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011520098A5 JP2011520098A5 JP2011505224A JP2011505224A JP2011520098A5 JP 2011520098 A5 JP2011520098 A5 JP 2011520098A5 JP 2011505224 A JP2011505224 A JP 2011505224A JP 2011505224 A JP2011505224 A JP 2011505224A JP 2011520098 A5 JP2011520098 A5 JP 2011520098A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- macers
- time point
- level
- score
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims description 34
- 108020001621 Natriuretic Peptide Proteins 0.000 claims description 19
- 102000004571 Natriuretic peptide Human genes 0.000 claims description 19
- 239000000692 natriuretic peptide Substances 0.000 claims description 19
- 230000002411 adverse Effects 0.000 claims description 5
- 208000024172 Cardiovascular disease Diseases 0.000 claims description 4
- 206010019280 Heart failures Diseases 0.000 claims description 4
- 230000000747 cardiac effect Effects 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 230000004936 stimulating effect Effects 0.000 claims description 3
- 206010002383 Angina Pectoris Diseases 0.000 claims description 2
- 101800000407 Brain natriuretic peptide 32 Proteins 0.000 claims description 2
- 102400000667 Brain natriuretic peptide 32 Human genes 0.000 claims description 2
- 101800002247 Brain natriuretic peptide 45 Proteins 0.000 claims description 2
- 102400001263 NT-proBNP Human genes 0.000 claims description 2
- 208000001647 Renal Insufficiency Diseases 0.000 claims description 2
- 102000046255 Type III Sodium-Phosphate Cotransporter Proteins Human genes 0.000 claims description 2
- 108091006286 Type III sodium-phosphate co-transporters Proteins 0.000 claims description 2
- 201000006370 kidney failure Diseases 0.000 claims description 2
- 231100000225 lethality Toxicity 0.000 claims description 2
- HPNRHPKXQZSDFX-OAQDCNSJSA-N nesiritide Chemical compound C([C@H]1C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1N=CNC=1)C(O)=O)=O)[C@@H](C)CC)C1=CC=CC=C1 HPNRHPKXQZSDFX-OAQDCNSJSA-N 0.000 claims description 2
- 210000002381 plasma Anatomy 0.000 claims description 2
- 108010008064 pro-brain natriuretic peptide (1-76) Proteins 0.000 claims description 2
- 210000002966 serum Anatomy 0.000 claims description 2
- 208000024891 symptom Diseases 0.000 claims description 2
- 238000002054 transplantation Methods 0.000 claims description 2
- 210000002700 urine Anatomy 0.000 claims description 2
- 235000009421 Myristica fragrans Nutrition 0.000 claims 2
- 239000001115 mace Substances 0.000 claims 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4615808P | 2008-04-18 | 2008-04-18 | |
| US61/046,158 | 2008-04-18 | ||
| PCT/US2009/040941 WO2009129454A2 (en) | 2008-04-18 | 2009-04-17 | Predicting risk of major adverse cardiac events |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014082442A Division JP5873521B2 (ja) | 2008-04-18 | 2014-04-14 | 主要有害心イベントのリスクを予測する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011520098A JP2011520098A (ja) | 2011-07-14 |
| JP2011520098A5 true JP2011520098A5 (https=) | 2012-12-27 |
| JP5526122B2 JP5526122B2 (ja) | 2014-06-18 |
Family
ID=41199760
Family Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011505224A Expired - Fee Related JP5526122B2 (ja) | 2008-04-18 | 2009-04-17 | 主要有害心イベントのリスクを予測する方法 |
| JP2014082442A Expired - Fee Related JP5873521B2 (ja) | 2008-04-18 | 2014-04-14 | 主要有害心イベントのリスクを予測する方法 |
| JP2016006007A Expired - Fee Related JP6200975B2 (ja) | 2008-04-18 | 2016-01-15 | 主要有害心イベントのリスクを予測する方法 |
| JP2017162932A Expired - Fee Related JP6484679B2 (ja) | 2008-04-18 | 2017-08-28 | 主要有害心イベントのリスクを予測する方法 |
| JP2019026401A Expired - Fee Related JP6788050B2 (ja) | 2008-04-18 | 2019-02-18 | 主要有害心イベントのリスクを予測する方法 |
| JP2020181010A Ceased JP2021039108A (ja) | 2008-04-18 | 2020-10-29 | 主要有害心イベントのリスクを予測する方法 |
Family Applications After (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014082442A Expired - Fee Related JP5873521B2 (ja) | 2008-04-18 | 2014-04-14 | 主要有害心イベントのリスクを予測する方法 |
| JP2016006007A Expired - Fee Related JP6200975B2 (ja) | 2008-04-18 | 2016-01-15 | 主要有害心イベントのリスクを予測する方法 |
| JP2017162932A Expired - Fee Related JP6484679B2 (ja) | 2008-04-18 | 2017-08-28 | 主要有害心イベントのリスクを予測する方法 |
| JP2019026401A Expired - Fee Related JP6788050B2 (ja) | 2008-04-18 | 2019-02-18 | 主要有害心イベントのリスクを予測する方法 |
| JP2020181010A Ceased JP2021039108A (ja) | 2008-04-18 | 2020-10-29 | 主要有害心イベントのリスクを予測する方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (5) | US8090562B2 (https=) |
| EP (5) | EP2660599B1 (https=) |
| JP (6) | JP5526122B2 (https=) |
| AU (3) | AU2009236109B2 (https=) |
| CA (1) | CA2720674A1 (https=) |
| DK (4) | DK3093663T3 (https=) |
| ES (4) | ES2687401T3 (https=) |
| HR (2) | HRP20131100T1 (https=) |
| HU (2) | HUE039963T2 (https=) |
| PL (4) | PL2269063T3 (https=) |
| PT (4) | PT3093663T (https=) |
| SI (4) | SI2827152T1 (https=) |
| WO (1) | WO2009129454A2 (https=) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002038794A2 (en) | 2000-11-09 | 2002-05-16 | The Brigham And Women's Hospital, Inc. | Cardiovascular disease diagnostic and therapeutic targets |
| DK3072978T3 (en) | 2002-05-09 | 2018-09-17 | Brigham & Womens Hospital Inc | : 1L1RL-1 AS A CARDIOVASCULAR DISEASE MARKER |
| AU2007244927B2 (en) | 2006-04-24 | 2012-01-12 | Critical Care Diagnostics, Inc. | Predicting mortality and detecting severe disease |
| ATE517341T1 (de) * | 2006-04-27 | 2011-08-15 | Critical Care Diagnostics Inc | Interleukin-33 (il-33) zur diagnose und vorhersage von herz-gefäss-erkrankungen |
| EP2021796B1 (en) | 2006-05-01 | 2012-02-08 | Critical Care Diagnostics, Inc. | Diagnosis of cardiovascular disease |
| PL2019965T3 (pl) * | 2006-05-02 | 2015-10-30 | Critical Care Diagnostics Inc | Rozpoznawanie różnicowe chorób układu oddechowego i sercowo-naczyniowego |
| US9968266B2 (en) | 2006-12-27 | 2018-05-15 | Cardiac Pacemakers, Inc. | Risk stratification based heart failure detection algorithm |
| PL2269063T3 (pl) | 2008-04-18 | 2014-04-30 | Critical Care Diagnostics Inc | Rokowanie ryzyka głównych niekorzystnych zdarzeń sercowych |
| JP5711131B2 (ja) * | 2008-10-07 | 2015-04-30 | ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 最初の有害事象の予測のためのバイオマーカー |
| US9561006B2 (en) * | 2008-10-15 | 2017-02-07 | The United States Of America As Represented By The Secretary Of The Navy | Bayesian modeling of pre-transplant variables accurately predicts kidney graft survival |
| US8417541B1 (en) * | 2009-08-27 | 2013-04-09 | Cerner Innovation, Inc. | Multi-stage model for predicting probabilities of mortality in adult critically ill patients |
| WO2011038305A2 (en) * | 2009-09-25 | 2011-03-31 | Volcano Corporation | Device and method for determining the likelihood of a patient having a clinical event or a clinically silent event based on ascertained physiological parameters |
| BR112012025728B1 (pt) * | 2010-04-09 | 2022-01-11 | Critical Care Diagnostics, Inc | Anticorpos isolados ou fragmentos que se liga a st2 humano solúvel, hibridoma, kit, bem como métodos para quantificação de um nível de st2 solúvel humano em uma amostra de um indivíduo, e para a predição do risco de morte dentro de um ano em um indivíduo |
| US10943676B2 (en) | 2010-06-08 | 2021-03-09 | Cerner Innovation, Inc. | Healthcare information technology system for predicting or preventing readmissions |
| ES2750126T3 (es) | 2011-03-17 | 2020-03-25 | Critical Care Diagnostics Inc | Procedimientos de predicción del riesgo de un resultado clínico adverso |
| DK2734222T3 (en) | 2011-07-18 | 2017-01-30 | Critical Care Diagnostics Inc | PROCEDURES FOR TREATING CARDIOVASCULAR DISEASES AND PREDICTING THE EFFECTIVENESS OF MOTION THERAPY |
| EP2637023A1 (en) * | 2012-03-08 | 2013-09-11 | B.R.A.H.M.S GmbH | Prediction of outcome in patients with chronic obstructive pulmonary disease |
| CA2873896A1 (en) | 2012-05-18 | 2013-11-21 | Critical Care Diagnostics, Inc. | Methods for treating or predicting risk of a ventricular tachyarrhythmia event |
| CN102830234A (zh) * | 2012-08-10 | 2012-12-19 | 杭州华得森生物技术有限公司 | 一种检测人心力衰竭新型标志物st2的快速诊断试剂盒 |
| MX382403B (es) | 2012-08-16 | 2025-03-13 | Critical Care Diagnostics Inc | Métodos para predecir el riesgo de desarrollar hipertensión. |
| CN104737170A (zh) | 2012-08-21 | 2015-06-24 | 重症监护诊断股份有限公司 | 多标记风险分层 |
| RU2510505C1 (ru) * | 2012-11-15 | 2014-03-27 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Тверская государственная медицинская академия" Министерства здравоохранения Российской Федерации | Способ определения вероятности выраженной сердечной недостаточности в клинической картине инфаркта миокарда |
| GB201310290D0 (en) * | 2013-06-10 | 2013-07-24 | Univ Manchester | Method for determining a probability of a major adverse cardiac event (MACE) |
| CA2935958A1 (en) * | 2014-01-10 | 2015-07-16 | Critical Care Diagnostics, Inc. | Methods and systems for determining risk of heart failure |
| ES2792227T3 (es) | 2014-09-26 | 2020-11-10 | Somalogic Inc | Predicción de evento de riesgo cardiovascular y usos de la misma |
| US10079073B2 (en) | 2014-12-11 | 2018-09-18 | Critical Care Diagnostics, Inc. | Test apparatus and methods for ST2 cardiac biomarker |
| US10324089B2 (en) | 2014-12-11 | 2019-06-18 | Critical Care Diagnostics, Inc. | Test apparatus and methods for ST2 cardiac biomarker |
| WO2016140958A1 (en) * | 2015-03-02 | 2016-09-09 | Estes Edward Harvey | Method and device to predict adverse cardiovascular events and mortality from an electrocardiogram-based validated risk score |
| EP4442200A3 (en) * | 2016-04-01 | 2024-12-04 | Cardiac Pacemakers, Inc. | Multi-disease patient management |
| AT518560B1 (de) * | 2016-04-18 | 2018-01-15 | Trumpf Maschinen Austria Gmbh & Co Kg | Biegebalken für eine Schwenkbiegemaschine |
| EP4445834A3 (en) | 2017-04-29 | 2024-12-25 | Cardiac Pacemakers, Inc. | Heart failure event rate assessment |
| US20200074313A1 (en) * | 2018-08-29 | 2020-03-05 | Koninklijke Philips N.V. | Determining features to be included in a risk assessment instrument |
| US11931207B2 (en) | 2018-12-11 | 2024-03-19 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device |
| US12322100B2 (en) | 2018-12-11 | 2025-06-03 | Eko.Ai Pte. Ltd. | Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and grading of aortic stenosis severity |
| US11446009B2 (en) | 2018-12-11 | 2022-09-20 | Eko.Ai Pte. Ltd. | Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images |
| US12400762B2 (en) | 2018-12-11 | 2025-08-26 | Eko.Ai Pte. Ltd. | Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and diagnosis of cardiac amyloidosis and hypertrophic cardiomyopathy |
| US12001939B2 (en) | 2018-12-11 | 2024-06-04 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views |
| EP3969620B1 (en) * | 2019-05-17 | 2025-06-25 | Regeneron Pharmaceuticals, Inc. | Genome-based methods for reducing cardiovascular risk |
| US11551817B2 (en) | 2020-01-14 | 2023-01-10 | International Business Machines Corporation | Assessing unreliability of clinical risk prediction |
| JP2024508975A (ja) * | 2021-03-08 | 2024-02-28 | サノフイ | 心血管疾患 |
| WO2023086746A1 (en) * | 2021-11-11 | 2023-05-19 | Beckman Coulter, Inc. | Assessment of risk for major adverse cardiac event |
| US12553310B2 (en) | 2023-09-07 | 2026-02-17 | Halliburton Energy Services, Inc. | Fire on demand barrier valve using wireless signal transmission and spring-forced piston |
Family Cites Families (87)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4208479A (en) | 1977-07-14 | 1980-06-17 | Syva Company | Label modified immunoassays |
| US5206140A (en) | 1988-06-24 | 1993-04-27 | Research Corporation Technologies, Inc. | Assay for soluble crosslinked fibrin polymers |
| US5217899A (en) | 1990-08-24 | 1993-06-08 | The General Hospital Corporation | Cell stretching apparatus |
| JP2665850B2 (ja) | 1991-11-14 | 1997-10-22 | 塩野義製薬株式会社 | ｈＢＮＰのＣ端を認識するモノクロ−ナル抗体 |
| GB9211686D0 (en) | 1992-06-03 | 1992-07-15 | Medisinsk Innovation A S | Chemical compounds |
| JP2732005B2 (ja) | 1992-12-14 | 1998-03-25 | 眞一 富永 | ヒトｓｔ２をコードするｄｎａ、該ｄｎａの発現産物、該ｄｎａを発現させることによる発現産物の製造方法 |
| JPH0731479A (ja) | 1993-02-23 | 1995-02-03 | Shinichi Tominaga | マウスｓｔ２ｌをコードするｄｎａ、該ｄｎａの発現産物、該ｄｎａを発現させることによる発現産物の製造方法 |
| US6066322A (en) | 1995-03-03 | 2000-05-23 | Millennium Pharmaceuticals, Inc. | Methods for the treatment of immune disorders |
| CA2263832A1 (en) | 1996-08-23 | 1998-02-26 | Human Genome Sciences, Inc. | T1 receptor-like ligand ii |
| WO1998038311A1 (en) | 1997-02-28 | 1998-09-03 | Human Genome Sciences, Inc. | T1/st2-receptor ligand iii |
| DE19711932A1 (de) | 1997-03-21 | 1998-09-24 | Anne Katrin Dr Werenskiold | In vitro-Verfahren zum Prognostizieren des Krankheitsverlaufs von Patienten mit Mammakarzinom und/oder zum Diagnostizieren eines Mammakarzinoms |
| ATE530180T1 (de) | 1997-04-02 | 2011-11-15 | Brigham & Womens Hospital | Verfahren zur ermittlung der individualen risikoprofile atherosklerotischen erkrankungen |
| CA2293718A1 (en) | 1997-06-10 | 1998-12-17 | Medlyte Diagnostics, Inc. | Methods for early detection of heart disease |
| CN1161609C (zh) | 1997-09-11 | 2004-08-11 | 盐野义制药株式会社 | 哺乳类γ－BNP衍生物特异的免疫测定方法及其试剂盒 |
| GB9727172D0 (en) | 1997-12-24 | 1998-02-25 | Univ Glasgow | Reagents specific for st2l and uses therefor |
| US6309888B1 (en) | 1998-09-04 | 2001-10-30 | Leuven Research & Development Vzw | Detection and determination of the stages of coronary artery disease |
| GB9827348D0 (en) * | 1998-12-12 | 1999-02-03 | Univ Leicester | Natriuretic peptide |
| AU2055300A (en) | 1998-12-18 | 2000-07-03 | Scios Inc. | Methods for detection and use of differentially expressed genes in disease states |
| WO2000073498A1 (en) | 1999-06-02 | 2000-12-07 | Millennium Pharmaceuticals, Inc. | Compositions and methods for the treatment and diagnosis of immune disorders |
| FR2795823B1 (fr) | 1999-07-01 | 2001-11-23 | Inst Nat Sante Rech Med | Methodes et kits pour le diagnostic ou le suivi d'une pathologie synoviale ou osteoarticulaire comprenant l'utilisation d'un marqueur specifique de la degradation du tissu synovial |
| EP1872797A3 (en) | 1999-08-24 | 2008-04-02 | Medicure International Inc. | Treatment of cardiovascular and related pathologies |
| US6323334B1 (en) | 1999-09-24 | 2001-11-27 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules encoding a 103 gene product and uses therefor |
| AU2001218871A1 (en) | 2000-03-21 | 2001-10-03 | Takao Arai | Monoclonal antibody and method and kit for the immunoassay of soluble human st2 with the use of the same |
| FR2807170B1 (fr) | 2000-03-30 | 2002-06-28 | Sipal | Charniere elastique a frottement reduit |
| EP1311547A2 (en) | 2000-08-22 | 2003-05-21 | The Brigham And Women's Hospital, Inc. | Diagnosis and treatment of cardiovascular conditions |
| WO2002038794A2 (en) | 2000-11-09 | 2002-05-16 | The Brigham And Women's Hospital, Inc. | Cardiovascular disease diagnostic and therapeutic targets |
| US6537221B2 (en) | 2000-12-07 | 2003-03-25 | Koninklijke Philips Electronics, N.V. | Strain rate analysis in ultrasonic diagnostic images |
| FI20010019L (fi) | 2001-01-05 | 2002-07-06 | Biohit Oyj | Menetelmä atrofisen diagnostisoimiseksi |
| US7713705B2 (en) | 2002-12-24 | 2010-05-11 | Biosite, Inc. | Markers for differential diagnosis and methods of use thereof |
| US20040253637A1 (en) | 2001-04-13 | 2004-12-16 | Biosite Incorporated | Markers for differential diagnosis and methods of use thereof |
| ATE458199T1 (de) | 2001-05-04 | 2010-03-15 | Biosite Inc | Diagnostische marker der akuten koronaren syndrome und ihre verwendungen |
| US6905827B2 (en) | 2001-06-08 | 2005-06-14 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases |
| WO2003022987A2 (en) | 2001-07-26 | 2003-03-20 | Eos Biotechnology, Inc. | Methods of diagnosis of hepatitis c infection, compositions and methods of screening for modulators of hepatitis c infection |
| US6810284B1 (en) | 2001-11-21 | 2004-10-26 | Pacesetter, Inc. | Implantable cardiac stimulation system and method for monitoring diastolic function |
| DK3072978T3 (en) | 2002-05-09 | 2018-09-17 | Brigham & Womens Hospital Inc | : 1L1RL-1 AS A CARDIOVASCULAR DISEASE MARKER |
| US20040005615A1 (en) | 2002-05-24 | 2004-01-08 | Jing Li | Amplification and overexpression of oncogenes |
| US8263325B2 (en) | 2002-11-15 | 2012-09-11 | Ottawa Heart Institute Research Corporation | Predicting, detecting and monitoring treatment of cardiomyopathies and myocarditis |
| JP2006507510A (ja) * | 2002-11-21 | 2006-03-02 | インバーネス・メデイカル・スウイツツアーランド・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング | 組織低酸素症の体液マーカー |
| WO2004056868A2 (en) | 2002-12-19 | 2004-07-08 | Endocube Sas | Nf-hev compositions and methods of use |
| US20040133079A1 (en) | 2003-01-02 | 2004-07-08 | Mazar Scott Thomas | System and method for predicting patient health within a patient management system |
| US20040220155A1 (en) | 2003-03-28 | 2004-11-04 | Pharmacia Corporation | Method of providing a steroid-sparing benefit with a cyclooxygenase-2 inhibitor and compositions therewith |
| US20050123451A1 (en) | 2003-10-31 | 2005-06-09 | Hiroshi Nomura | System and apparatus for body fluid analysis using surface-textured optical materials |
| CA2547072C (en) | 2003-11-26 | 2015-06-23 | Applera Corporation | Single nucleotide polymorphisms associated with cardiovascular disorders and statin response, methods of detection and uses thereof |
| EP2306192B1 (en) | 2003-12-05 | 2015-10-14 | The Cleveland Clinic Foundation | Risk Markers For Cardiovascular Disease |
| US20050196817A1 (en) | 2004-01-20 | 2005-09-08 | Molecular Staging Inc. | Biomarkers for sepsis |
| NZ549040A (en) | 2004-02-17 | 2009-07-31 | Schering Corp | Use for interleukin-33 (IL33) and the IL-33 receptor complex |
| JP2005291899A (ja) | 2004-03-31 | 2005-10-20 | Akira Matsumori | 心疾患の検査法 |
| US20060196817A1 (en) | 2004-12-17 | 2006-09-07 | Clearwater Systems Corporation | Method and apparatus for treating fluids |
| EP1849009B1 (en) | 2005-01-24 | 2008-10-29 | F. Hoffmann-La Roche AG | The use of cardiac hormones for assessing a cardiovascular risk with respect to the administration of anti-inflammatory drugs. |
| EP1731910A1 (en) * | 2005-06-07 | 2006-12-13 | F. Hoffmann-La Roche Ag | Use of NT-proANP and NT-proBNP for diagnosing cardiac diseases |
| US20070021977A1 (en) | 2005-07-19 | 2007-01-25 | Witt Biomedical Corporation | Automated system for capturing and archiving information to verify medical necessity of performing medical procedure |
| JP4820192B2 (ja) | 2006-03-17 | 2011-11-24 | 一般財団法人化学及血清療法研究所 | 急性冠症候群でのａｄａｍｔｓ１３の測定と利用 |
| AU2007244927B2 (en) | 2006-04-24 | 2012-01-12 | Critical Care Diagnostics, Inc. | Predicting mortality and detecting severe disease |
| ATE517341T1 (de) | 2006-04-27 | 2011-08-15 | Critical Care Diagnostics Inc | Interleukin-33 (il-33) zur diagnose und vorhersage von herz-gefäss-erkrankungen |
| EP2021796B1 (en) * | 2006-05-01 | 2012-02-08 | Critical Care Diagnostics, Inc. | Diagnosis of cardiovascular disease |
| PL2019965T3 (pl) | 2006-05-02 | 2015-10-30 | Critical Care Diagnostics Inc | Rozpoznawanie różnicowe chorób układu oddechowego i sercowo-naczyniowego |
| US8147817B2 (en) | 2006-05-04 | 2012-04-03 | The Brigham And Women's Hospital, Inc. | IL-33 in the treatment and diagnosis of diseases and disorders |
| EP2302395B1 (en) * | 2006-06-07 | 2015-04-15 | Health Diagnostic Laboratory, Inc. | Markers associated with arteriovascular events and methods of use thereof |
| RU2312591C1 (ru) | 2006-06-14 | 2007-12-20 | Государственное образовательное учреждение высшего профессионального образования "Санкт-Петербургская государственная медицинская академия им. И.И. Мечникова Федерального агентства по здравоохранению и социальному развитию" | Способ прогнозирования развития риска внезапной смерти у больных с лево- и правожелудочковой экстрасистолией |
| US20080233191A1 (en) | 2007-03-22 | 2008-09-25 | Brent Blackburn | Use of ranolazine for elevated brain-type natriuretic peptide |
| US20090111708A1 (en) | 2007-05-11 | 2009-04-30 | Seddon Johanna M | Polynucleotides associated with age-related macular degeneration and methods for evaluating patient risk |
| GB0713404D0 (en) | 2007-07-11 | 2007-08-22 | Integra Sp Ipr Ltd | Altio graph |
| US20100267062A1 (en) | 2007-09-26 | 2010-10-21 | Norbert Frey | Osteopontin as Novel Prognostic Biomarker for Heart Failure |
| FR2923029B1 (fr) | 2007-10-26 | 2009-11-20 | Minima | Lunettes de type sans entourage a branches filaires |
| PL2269063T3 (pl) | 2008-04-18 | 2014-04-30 | Critical Care Diagnostics Inc | Rokowanie ryzyka głównych niekorzystnych zdarzeń sercowych |
| WO2010025393A2 (en) * | 2008-08-28 | 2010-03-04 | The Regents Of The University Of California | Protein biomarkers and methods for diagnosing kawasaki disease |
| US20100159474A1 (en) | 2008-11-11 | 2010-06-24 | B.R.A.H.M.S. Aktiengesellschaft | Prognosis and risk assessment in patients suffering from heart failure by determining the level of adm and bnp |
| KR20120101064A (ko) | 2009-11-13 | 2012-09-12 | 비쥐 메디신, 인코포레이티드 | 심근 경색의 위험 인자 및 예측 |
| US8258456B2 (en) | 2009-11-27 | 2012-09-04 | Himax Imaging, Inc. | Image sensor |
| BR112012025728B1 (pt) | 2010-04-09 | 2022-01-11 | Critical Care Diagnostics, Inc | Anticorpos isolados ou fragmentos que se liga a st2 humano solúvel, hibridoma, kit, bem como métodos para quantificação de um nível de st2 solúvel humano em uma amostra de um indivíduo, e para a predição do risco de morte dentro de um ano em um indivíduo |
| WO2012059477A1 (en) | 2010-11-01 | 2012-05-10 | B.R.A.H.M.S Gmbh | Prognosis and risk assessment of patients with non-specific complaints |
| RU2452394C1 (ru) | 2010-11-09 | 2012-06-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Ульяновский государственный университет | Способ прогнозирования риска смерти больных хронической сердечной недостаточностью |
| ES2750126T3 (es) | 2011-03-17 | 2020-03-25 | Critical Care Diagnostics Inc | Procedimientos de predicción del riesgo de un resultado clínico adverso |
| US8615387B2 (en) * | 2011-04-07 | 2013-12-24 | Invensys Systems, Inc. | Dynamic simulation of fluid filled vessels |
| DK2734222T3 (en) | 2011-07-18 | 2017-01-30 | Critical Care Diagnostics Inc | PROCEDURES FOR TREATING CARDIOVASCULAR DISEASES AND PREDICTING THE EFFECTIVENESS OF MOTION THERAPY |
| CA2873896A1 (en) | 2012-05-18 | 2013-11-21 | Critical Care Diagnostics, Inc. | Methods for treating or predicting risk of a ventricular tachyarrhythmia event |
| MX382403B (es) * | 2012-08-16 | 2025-03-13 | Critical Care Diagnostics Inc | Métodos para predecir el riesgo de desarrollar hipertensión. |
| CN104737170A (zh) | 2012-08-21 | 2015-06-24 | 重症监护诊断股份有限公司 | 多标记风险分层 |
| US9665593B2 (en) * | 2013-03-28 | 2017-05-30 | International Business Machines Corporation | Dynamically synching elements in file |
| JP6178687B2 (ja) | 2013-09-27 | 2017-08-09 | 富士機械工業株式会社 | グラビア塗工装置 |
| CA2935958A1 (en) | 2014-01-10 | 2015-07-16 | Critical Care Diagnostics, Inc. | Methods and systems for determining risk of heart failure |
| USD770057S1 (en) | 2014-04-14 | 2016-10-25 | Critical Care Diagnostics, Inc. | Blood test kit |
| US9934249B2 (en) | 2014-06-03 | 2018-04-03 | Conduent Business Machines Services, Llc | Systems and methods for context-aware and personalized access to visualizations of road events |
| USD800333S1 (en) | 2014-09-23 | 2017-10-17 | Critical Care Diagnostics, Inc. | Blood test kit |
| USD800332S1 (en) | 2014-09-23 | 2017-10-17 | Critical Care Diagnostics, Inc. | Blood test kit |
| US10324089B2 (en) | 2014-12-11 | 2019-06-18 | Critical Care Diagnostics, Inc. | Test apparatus and methods for ST2 cardiac biomarker |
| US10079073B2 (en) | 2014-12-11 | 2018-09-18 | Critical Care Diagnostics, Inc. | Test apparatus and methods for ST2 cardiac biomarker |
-
2009
- 2009-04-17 PL PL09731842T patent/PL2269063T3/pl unknown
- 2009-04-17 SI SI200931469A patent/SI2827152T1/sl unknown
- 2009-04-17 ES ES16166093.1T patent/ES2687401T3/es active Active
- 2009-04-17 ES ES14177846.4T patent/ES2590213T3/es active Active
- 2009-04-17 PL PL14177846.4T patent/PL2827152T3/pl unknown
- 2009-04-17 CA CA2720674A patent/CA2720674A1/en not_active Abandoned
- 2009-04-17 DK DK16166093.1T patent/DK3093663T3/en active
- 2009-04-17 HR HRP20131100AT patent/HRP20131100T1/hr unknown
- 2009-04-17 EP EP13179055.2A patent/EP2660599B1/en not_active Not-in-force
- 2009-04-17 US US12/425,956 patent/US8090562B2/en active Active
- 2009-04-17 AU AU2009236109A patent/AU2009236109B2/en not_active Ceased
- 2009-04-17 PT PT16166093T patent/PT3093663T/pt unknown
- 2009-04-17 PL PL16166093T patent/PL3093663T3/pl unknown
- 2009-04-17 PT PT131790552T patent/PT2660599E/pt unknown
- 2009-04-17 EP EP18166387.3A patent/EP3378955A1/en not_active Withdrawn
- 2009-04-17 SI SI200931872T patent/SI3093663T1/sl unknown
- 2009-04-17 WO PCT/US2009/040941 patent/WO2009129454A2/en not_active Ceased
- 2009-04-17 DK DK14177846.4T patent/DK2827152T3/en active
- 2009-04-17 ES ES13179055.2T patent/ES2525029T3/es active Active
- 2009-04-17 SI SI200931045T patent/SI2660599T1/sl unknown
- 2009-04-17 SI SI200930776T patent/SI2269063T1/sl unknown
- 2009-04-17 DK DK09731842.2T patent/DK2269063T3/da active
- 2009-04-17 ES ES09731842.2T patent/ES2443125T3/es active Active
- 2009-04-17 DK DK13179055.2T patent/DK2660599T3/en active
- 2009-04-17 HU HUE16166093A patent/HUE039963T2/hu unknown
- 2009-04-17 EP EP14177846.4A patent/EP2827152B1/en not_active Not-in-force
- 2009-04-17 HU HUE14177846A patent/HUE029880T2/en unknown
- 2009-04-17 EP EP16166093.1A patent/EP3093663B1/en not_active Not-in-force
- 2009-04-17 PL PL13179055T patent/PL2660599T3/pl unknown
- 2009-04-17 EP EP09731842.2A patent/EP2269063B1/en not_active Not-in-force
- 2009-04-17 PT PT141778464T patent/PT2827152T/pt unknown
- 2009-04-17 JP JP2011505224A patent/JP5526122B2/ja not_active Expired - Fee Related
- 2009-04-17 PT PT97318422T patent/PT2269063E/pt unknown
-
2011
- 2011-11-18 US US13/299,612 patent/US20120065897A1/en not_active Abandoned
-
2013
- 2013-03-06 US US13/787,137 patent/US9886553B2/en not_active Expired - Fee Related
-
2014
- 2014-04-03 US US14/244,526 patent/US9965593B2/en active Active
- 2014-04-14 JP JP2014082442A patent/JP5873521B2/ja not_active Expired - Fee Related
- 2014-11-03 HR HRP20141056AT patent/HRP20141056T1/hr unknown
-
2016
- 2016-01-15 JP JP2016006007A patent/JP6200975B2/ja not_active Expired - Fee Related
- 2016-02-04 AU AU2016200697A patent/AU2016200697B2/en not_active Ceased
-
2017
- 2017-08-28 JP JP2017162932A patent/JP6484679B2/ja not_active Expired - Fee Related
-
2018
- 2018-04-04 AU AU2018202350A patent/AU2018202350A1/en not_active Abandoned
- 2018-04-12 US US15/951,376 patent/US11170896B2/en active Active
-
2019
- 2019-02-18 JP JP2019026401A patent/JP6788050B2/ja not_active Expired - Fee Related
-
2020
- 2020-10-29 JP JP2020181010A patent/JP2021039108A/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011520098A5 (https=) | ||
| JP6484679B2 (ja) | 主要有害心イベントのリスクを予測する方法 | |
| JP2019105645A5 (https=) | ||
| Salgado-Somoza et al. | The circular RNA MICRA for risk stratification after myocardial infarction | |
| JP6757757B2 (ja) | 高血圧症を発症するリスクを予測するための方法 | |
| Adamopoulos et al. | Effects of growth hormone on circulating cytokine network, and left ventricular contractile performance and geometry in patients with idiopathic dilated cardiomyopathy | |
| JP7565291B2 (ja) | 消化管手術を受けた患者のｍａｃｃｅの診断方法 | |
| CN111500710B (zh) | circRNA730作为生物标志物在预测、诊断或预后脓毒症中的用途 | |
| Hadzibegovic et al. | Heart failure with preserved ejection fraction according to the HFA-PEFF score in COVID-19 patients: clinical correlates and echocardiographic findings | |
| Chatzistamatiou et al. | Nocturnal hypertension: poor correlation with office blood pressure but strong prognostic factor for target organ damage | |
| Kievit et al. | Efficient selective screening for heart failure in elderly men and women from the community: A diagnostic individual participant data meta-analysis | |
| Zoltowska et al. | Association between hypothyroidism and takotsubo cardiomyopathy: analysis of nationwide inpatient sample database | |
| Tang et al. | Is CHA2DS2-VASc score a predictor of left atrial thrombus in patients with paroxysmal atrial fibrillation? | |
| Rizzi et al. | Unfavorable donor pretransplant APACHE II, SAPS II, and SOFA scores are not associated with outcome: implications for heart transplant donor selection | |
| Maeder et al. | N-terminal pro-B-type natriuretic peptide and functional capacity in patients with obstructive sleep apnea | |
| RU2014107752A (ru) | Среднерегиональный предшественник предсердного натрийуретического пептида (pro-anp) для идентификации пациентов с фибрилляцией предсердий, начавшейся меньше, чем 48 часов тому назад | |
| JP2017534874A5 (https=) | ||
| Vallejo-Vaz | Novel biomarkers in heart failure beyond natriuretic peptides—the case for soluble ST2 | |
| WO2012078502A3 (en) | Biomarker test for acute coronary syndrome | |
| Cong et al. | Predictive value of brachial-ankle artery pulse wave velocity to heart failure with preserved ejection fraction in hospitalised patients with acute dyspnoea | |
| Hermany et al. | Cardiac Biomarkers in Transcatheter Aortic Valve Implantation | |
| RU2446733C1 (ru) | Способ прогноза инфаркта миокарда у больных коронарной болезнью сердца | |
| Oskouie et al. | CS as a Novel Biomarker for Diagnosis of Cardiac Allograft Rejection | |
| Berner et al. | The Assessment of Cardiovascular Risk in Patients with Acute Decompensated Heart Failure Accompanied by Chronic Kidney Disease | |
| Lin et al. | PTU-089 Follow-up of patients with primary sclerosing cholangitis–do we meet international standards? |